There are many new and exciting studies in the sedation literature. Recent studies of new scoring systems to monitor sedation, new medications, and new insights into post-intensive care unit (ICU) sequelae have brought about interesting ideas for achieving an adequate level of sedation of our patients while minimizing complications.
Introduction
The need for mechanical ventilation is one of the principal reasons a patient is admitted to the intensive care unit (ICU). Whether the indication is to provide adequate ventilation, to provide increased oxygenation, or to secure an airway, providing the patient with adequate comfort while he or she is being mechanically ventilated is imperative. Most patients admitted to an ICU for mechanical ventilation will receive one or more sedative medications [1] [2] [3] . In this review, we discuss sedation indications, medications, protocols, and monitoring systems. The focus is on recent literature, highlighting seminal studies.
Distinguishing pain from other causes of agitation
Patients on a ventilator are often unable to adequately communicate their needs, including their need for pain control. The agitated patient who is "bucking the vent" may be doing so secondary to significant pain. It should be remembered that none of the drugs commonly used for sedation provide analgesia. Many patients in the ICU recall significant unrelieved pain [4] [5] [6] . Whether from trauma, a surgical incision, an invasive procedure, or even simply the presence of the endotracheal tube and airway suctioning, pain should be controlled. The Joint Commission for Accreditation of Healthcare Organizations has mandated the monitoring of pain in all patients [7] . Opioid medications have demonstrated synergistic effects with sedative drugs, particularly benzodiazepines, and combined use of an analgesic and a sedative often results in lesser doses of each [8, 9] . In some patients, an opioid analgesic alone will achieve both pain control and tranquility. With occasional exceptions, all patients admitted to our ICU receive opioid analgesia. The algorithm outlined in Figure 1 offers an approach to assessing an agitated patient receiving mechanical ventilation.
Why we sedate
There are many reasons why a patient on a ventilator needs to be sedated. Being in the ICU on a ventilator can be very anxiety provoking [3, 4] . The patient is often aware that he or she is in a life-threatening situation. Post-ICU surveys indicate inability to communicate and a lack of control as two leading causes of anxiety in the ICU [10•]. A patient's need for sedating medication can be high, depending on the indication for intubation. For example, a patient in status asthmaticus undergoing a strategy of permissive hypercapnea during mechanical ventilation may require more sedative to overcome the respiratory drive from a climbing CO 2 level, whereas a long-term emphysema patient may require little or no sedation for ventilatory failure [11, 12] .
The traumatic self-removal of an endotracheal tube puts the patient at risk for vocal cord trauma, aspiration, bleeding, and hypoxia and can be life threatening. Unintended removal of arterial and venous catheters can result in bleeding and interruption of pharmacotherapies and can necessitate additional procedures carrying risk. Patients on mechanical ventilation can be confused and delirious and sometimes combative and violent. Often, the patient is physically restrained, but this may negatively impact post-ICU psychological recovery [13, 14] , and family members are often concerned about physical restraints [15] . Adequate sedation to facilitate care by the ICU team is imperative to ensure that the patient receives safe and proper care.
Amnesia for some ICU experiences may be a reasonable goal of sedation. Many patients have a memory of being uncomfortable while in the ICU [10,16•,17•], but this memory can in part relate to inadequate analgesia. Complete amnesia for the duration of critical illness may carry adverse consequences. There is some evidence that lack of memory of a critical illness may predispose patients to long-term psychological problems [13, 14, [18] [19] [20] [21] . More research into the long-term psychological outcomes of the survivors of critical illness needs to be performed. Our approach has always been to ensure adequate analgesia and sedation, but not to focus on amnesia per se. In fact, follow-up studies at our own institution tracking long-term consequences of daily interruption of sedation and awakening patients have shown no adverse neuropsychiatric sequelae [22] .
In all patients receiving neuromuscular blockade complete and deep sedation is mandatory [23,24••] . No strategies of daily awakening or intermittent dosing should be employed unless they are linked to prior cessation of neuromuscular blockade. Interactive scoring systems are obviously not employed in patients receiving neuromuscular blockade, but paralysis should be followed by electrophysiologic assessment with a nerve stimulator [25••].
Complications of sedation
The drugs used for sedation and analgesia in the ICU have a broad range of half-lives, can have impaired metabolism related to the frequent organ failures associated with critical illness, and exhibit many drug-drug interactions. These complicating issues not withstanding, a common complication of sedation is drug accumulation with protracted depression of central nervous system function. The consequences of "oversedating" a patient are many. Continuous infusion of sedation has been associated with prolonged time on the ventilator, prolonged ICU stays, prolonged hospital stays, increased utilization of diagnostic procedures and imaging modalities, and difficulty in adequately monitoring a patient's neurologic function [26, 27] . Differing strategies have been proposed and evaluated to achieve both adequate sedation and avoidance of excessive drug effect.
The continuous infusion of opioids and benzodiazepines raises the possibility of a patient developing a physical addiction to these medications. The agitation and restlessness of a ventilated patient during liberation from mechanical ventilation may relate in large part to withdrawal symptoms. This problem affects patient populations of all ages [28] [29] [30] [31] . Although almost all studies on this subject are retrospective, no precise correlation between quantity and duration of drug exposure predicts dependency. Most patients exhibiting withdrawal from opioids and benzodiazepines will either have had significant exposure prior to their critical illness or will have received high doses of drugs for more than 3 to 5 days during their ICU management [30] . In a prospective study of infants, higher total dose and duration of fentanyl administration were associated with the development of withdrawal symptoms [32] . The incidence of withdrawal symptoms has been shown to increase with concurrent use of neuromuscular blockade and prolonged use of sedatives and analgesics [33] . Management of this problem should be multifaceted. Options include the use of medications such as clonidine to control withdrawal symptoms, switching the patient to longer acting forms of medications such as methadone and diazepam, using the expertise of a behavioral psychologist, and, on occasion, employing antidepressant and antipsychotic 
Drugs and routes of administration
The drugs used for sedation in the ICU are extensively reviewed in the literature [35,36••] . For practical reasons related to maintaining a closed inhalation-exhalation circuit, use of gas anesthesia (e.g., isoflurane) is not routine in the ICU, despite its efficacy [37•].
Opioids
Opioid drugs (morphine, methadone, hydromorphone, fentanyl) are used in most critically ill patients. Meperidine should not be used because the pro-drug and active metabolite accumulate in patients with renal dysfunction, resulting in prolonged opioid effect as well as neurotoxicity manifested as delirium, myoclonus, and seizures. The use of a pain scale to quantify pain and titrate analgesia in the interactive patient should be routine [38] [39] [40] [41] . Studies of many different patient populations routinely indicate that physicians and nurses provide inadequate pain relief [42] [43] [44] [45] [46] [47] . Studies of ICU survivors indicate a high recollection of pain [10, 48] .
Benzodiazepines
Benzodiazepines (diazepam, lorazepam, midazolam) are frequently used to provide anxiolysis. It is important to understand that these drugs provide no pain relief. Pain should always be assessed before the use of sedatives. Also, opioids and benzodiazepines have synergistic effects, allowing for lower doses of both drugs to be used [8, 9] . The kinetics of drug metabolism and the volume of distribution of benzodiazepine drugs change during critical illness, especially in patients with impaired renal and hepatic function [49] [50] [51] [52] [53] . Even drugs considered ultrashort acting when given as a single bolus (such as midazolam) may accumulate when given by continuous infusion or repeated bolus in the critically ill patient [49, 52] .
Propofol
Propofol is an alkylphenol anesthetic that has been reviewed recently [54••] . It provides no analgesia and when used concurrently with opioids may require higher analgesic dosing than is needed with benzodiazepines [55] . Propofol has a short half-life and a rapid onset of action but has not been shown to be superior to other sedating agents [56] [57] [58] . The ventilatory depression can be profound, and propofol should be used only in a patient with a secured airway or with staff immediately available to intubate. Propofol is insoluble in water, so it is delivered in a lipid emulsion, which can lead to elevated triglyceride levels [59, 60] . Patients on total parenteral nutrition must have their lipid infusion adjusted if receiving propofol, and all patients receiving propofol should have baseline, 72-hour, and then weekly triglyceride levels measured; if significant elevations in triglyceride occur, the infusion should be stopped [54••] A maximum dose of 75 µg/kg/min is recommended to minimize the possibility of a propofol infusion syndrome. First described in a pediatric population, but also seen in adults, the syndrome involves profound myocardial failure and severe lactic acidosis [54••,61] .
Other agents
Haloperidol is still used in some ICUs as a primary sedative. It has no analgesic or amnesic properties and has a long half-life. An optimal dose and regimen for haloperidol administration has not been defined [62••] . Patients receiving haloperidol demonstrate indifference to their surrounding environment and may even have cataleptic immobility, making it difficult to perform pain and sedation assessment [63] . The principal concern with the use of haloperidol is extrapyramidal effects, hypotension, and prolongation of the QT-interval. A case-controlled study, using historical controls, suggested an incidence of torsades de pointes of 3.6% [64] . Haloperidol is useful for treating patients with acute agitation and with psychotic behavior but should not be used as a primary agent for sedation.
Dexmedetomidine is a lipophilic derivative of imidazole, recently approved for use in the United States. The drug has a high affinity for ␣ 2 -adrenoreceptors and has sedative, analgesic, and sympatholytic effects [65] . In early studies in the ICU and the operating room, it has been shown to reduce the quantity of intravenous sedation, inhalation anesthesia, and intravenous opioid administered, while also providing anxiolysis, improved perioperative hemodynamic stability, and no suppression of respiratory drive [66•,67,68,69•]. In volunteers, the drug has allowed easy arousal from a sedated state as well as a quick return to their previous sedation level. This has also been demonstrated in postoperative patients and the critically ill [70•,71] . In a randomized double-blind study in patients who spent less than 24 hours on the ventilator, dexmedetomidine was associated with less use of propofol and morphine [69•]. Although initial data regarding dexmedetomidine are promising, the lack of large randomized trials demonstrating decreased mechanical ventilation time precludes recommending the routine use of this medication at present.
Monitoring of sedation
It has been shown that early use of a spontaneous breathing trial (SBT) reduces time spent on the ventilator [72] . To perform a SBT, however, the patient ideally is awake and interactive with care providers. Patients often receive continuous infusions of sedative medications in the ICU, but this has been shown to lead to prolonged intubation and mechanical ventilation [26] . Various scales to assess level of sedation have been developed, all with the goal of permitting the bedside clinician to adjust the sedative dose to achieve adequate but not excessive sedation.
An objective scale to measure sedation would have multiple benefits for the mechanically ventilated patient. Aside from allowing for easy communication among those caring for the patient, it would also control for differing opinions among the health care team regarding the level of sedation: An agreed upon number on the sedation scale would become the goal of care.
Several bedside measurement scales have been developed to assess a patient's level of sedation. Most of the literature regarding sedation has used the Ramsay Sedation Scale (Table 1) , developed in 1974 [73] . However, the Ramsay scale was not originally intended to be used as a tool for clinical monitoring and has not been rigorously tested for reliability and validity.
The recently introduced Richmond Agitation and Sedation Scale (RASS) has proved to be a useful bedside tool in the management of sedation (Table 2 ). This scale was developed by a multidisciplinary team using a 10-point scale that is rated using three well-defined steps [74••] . Scoring is simple to perform after minimal training, allowing the scale to be an extremely useful clinical and research tool. Besides being easy to learn and perform, the RASS has the unique feature of measuring length of eye contact by the patient following verbal command. Two components of consciousness are arousal and content of thought, and by measuring degree of eye contact, the RASS more effectively allows the measurement of consciousness in the sedated patient. Studies of reliability among various members of the medical team and in differing patient populations demonstrate excellent inter-rater correlation across a variety of patient populations [74••,75••] . Randomized trials measuring reduction in time on ventilators or time in the ICU comparing a targeted RASS versus no scoring system, intermittent sedation, or daily awakenings have not been published to date.
The inherent problem with all scoring systems is the subjective nature of the measurements. A tool that could objectively measure level of sedation has theoretical appeal. One such tool that is being studied is the Bispectral Index Score (BIS). The BIS is a numeric value from 0 (deep sedation) to 100 (awake) derived from complex mathematical analysis of the electroencephalogram. The BIS number comes from an electroencephalographic database derived from normal volunteers who were given one or more sedative drugs. A BIS of 45 to 60 has been shown to correlate with a low probability of response to verbal stimulation in this non-critically ill population. To date, small studies have shown moderate to good correlation with scoring systems such as Ramsay in adults and COMFORT in children, but randomized trials demonstrating improved outcomes with routine BIS monitoring have not been performed [76•,77] . Other studies have not demonstrated a good correlation of BIS to other measures of level of sedation, especially in a heterogeneous surgical population [78] .
Management of sedation
Ely et al. demonstrated that early SBT decreased the time spent on the ventilator [72] , whereas Kollef observed that the continuous infusion of sedatives increased the time spent on the ventilator [26] . Other studies further demonstrated that a protocol-driven approach to mechanical ventilation and SBTs lead to reduced time on the ventilator, but oversedation remained a principal reason for failure to implement a ventilator weaning [79] [80] [81] [82] . How does one reconcile the competing goals of providing adequate sedation and the need to interact with patients so they can be easily liberated from the ventilator?
Daily interruption of sedation
Kress et al. clearly demonstrated that daily interruption of continuous sedation decreased the length of time patients spend on the ventilator (Fig. 2) and in the ICU and diminished the number of diagnostic tests performed to evaluate why a patient was not waking up once sedatives had been discontinued [27] . The protocol involved the daily stopping of the continuous drug infusion (including opiates) and monitoring the patient until he or she started to show signs of awakening. The drugs were then re-started at half the previous dose and were titrated at the discretion of the bedside nurse to achieve a Ramsay sedation score of 3 to 4. In comparison with routine management, the daily cessation of drug infusions significantly reduced time on the ventilator and in the ICU and provided a valuable window of opportunity for assessment of the patient's neurologic function. Interestingly, when the data in this trial were analyzed by drug used (Fig. 3) , little difference was noted, making the point that the particular agent used might be less important than the protocol used to titrate drug administration.
Intermittent administration of sedation
The observation by Kollef et al. that the continuous intravenous infusion of sedative medication prolonged mechanical ventilation and increased the length of stay in the ICU provided the rationale to give sedation through intermittent infusions [26] . No studies to date demonstrate an improved length of stay in the ICU using this strategy of sedation.
Recommendations by organizations
A few published guidelines exist to aid the physician in achieving the goals of sedation [36,62••]. The American College of Critical Care Medicine, under the auspices of the Society of Critical Care Medicine, published practice parameters in 1995 for the optimal use of sedatives and analgesics in the critically ill patient [83] . These were updated in 2002 [62••] . Despite these recommendations, there is little standardization regarding the management of ICU sedation. Within the same hospital, different sedation strategies are often implemented, with a wide range of physician and nurse views of how best to identify and approach adequate and excessive sedation [84] . In our experience, approaches are often governed by historical or institutional biases and not adequately informed by evidence.
Conclusion
The treating physician should provide comfort to the mechanically ventilated patient, and a continuous assessment of a patient's pain control should be routine. Once adequate analgesia with opioid medication is achieved, a patient who is still uncomfortable should be sedated with either propofol or a benzodiazepine if comfort cannot be achieved by manipulating the ventilator or physical environment. Dexmedetomidine seems to hold great promise, but further study in the critically ill patient should be undertaken before the routine use of this drug can be recommended. Sedative medication should be given by continuous intravenous infusion, with a target RASS score of 0. The possible role of BIS in minimizing sedation complications has not been fully delineated. Patients should undergo daily interruption of their sedative medication to allow assessment of neurologic function, potential for SBT, and assessment of analgesia. As a patient is being liberated from sedative medications, a careful assessment of signs and symptoms of withdrawal from opioids and benzodiazepines should be assessed. Post-ICU care of the formerly mechanically ventilated patient should involve careful monitoring for signs of depression, anxiety, drug abuse, and post-traumatic stress disorder.
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